02157.HK

Aug 19, 2026, 08:42 UTC

Lepu Biopharma announced its interim results for the six months ended June 2026, with revenue of RMB 522 million, up 12.1% year-on-year, and net profit of RMB 27.39 million, down 34.4% year-on-year.